Jordan Julie reported NGNE

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001968554-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Feb 20, 2026

Published

Feb 24, 2026

Ingested by INSIDER

Nov 5, 04:15 UTC

Last re-read

Nov 5, 04:15 UTC

Extracted facts

Filer

Jordan Julie

Role

Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

Neurogene Inc. — Stock Option (Right to Buy)

Ticker

NGNE

Shares

29.6K

Price per share

$0

Execution date (reported)

Feb 20, 2026

Owned after transaction

29.6K shares

Days from execution to publication

4

What this establishes

Jordan Julie filed this Form 4 reporting a grant or award of NGNE on Feb 20, 2026. It became public on Feb 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Jordan Juliecik:0001968554

Issuer

Neurogene Inc.cik:0001404644

Revision history · 0

No field has changed since this record was first ingested.